Quick Answer
Connect Biopharma Holdings Ltd reported Total Assets of $56.08 million for fiscal year 2025.
Connect Biopharma Holdings Ltd Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $56.08M | -44.6% |
| 2024 | $101.28M | -20.5% |
| 2023 | $127.38M | -26.8% |
| 2022 | $174.01M | -40.2% |
| 2021 | $291.05M | -73.2% |
| 2020 | $1.08B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $67.36M | — | -18.6% |
| June 30, 2025 | $82.72M | — | -10.7% |
| March 31, 2025 | $92.69M | — | -8.5% |
| December 31, 2024 | $101.28M | — | — |
- Connect Biopharma Holdings Ltd showed a decrease of -44.6% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Connect Biopharma Holdings Ltd’s total assets has declined by 94.8% (from $1.08 billion to $56.08 million).
- The most recent figure is from Connect Biopharma Holdings Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: